The Great Trade of 2023 is now complete. On Friday, the Chicago Bears nabbed University of Missouri wide receiver Luther Burden III with the 39th overall pick of the 2025 NFL draft. That selection ...

FORT HOOD, Texas (KWTX) - 200 men and women in uniform are taking part in a U.S. Army trial program called FEED. “The program allows the soldiers, the meal card holders, to utilize their meal ...

A National Aeronautics and Space Administration (NASA) pilot program will utilize citizen science to help expedite hurricane disaster recovery. The space agency -- along with the Globe Program, a ...

The Army is trying out new ways to feed soldiers who can’t make it to a post dining facility during opening hours. Service members work a lot, and the limited operating hours of mess halls across the ...

Google confirmed the 100 million milestone exclusively to CNET. Here's what's coming next for Flow and its AI-assisted creators. Katelyn is a writer with CNET covering artificial intelligence, ...

FORT HOOD, Texas — The Army for the first time this week granted 200 soldiers the power to use their military ID card to buy food outside of the dining facility with their meal entitlements. For the ...

FEED will allow Soldiers to use their meal entitlements outside of traditional Army-operated dining facilities for the first time. During the pilot, 200 Soldiers from the 61st Quartermaster Battalion ...

PHILADELPHIA (WPVI) -- There are more than 198,000 students in the School District of Philadelphia, and nearly a quarter of them rely on SEPTA to get to class. Unless lawmakers agree on a ...

Suzanne Blake is a Newsweek reporter based in New York. Her focus is reporting on consumer and social trends, spanning from retail to restaurants and beyond. She is a graduate of UNC Chapel Hill and ...

Engineers at NASA’s Marshall Space Flight Center in Huntsville, Alabama, conducted a hot fire test of a full-scale Rotating Detonation Rocket Engine combustor in fall 2023. Credit: NASA HUNTSVILLE, ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 agonist, ...